PMC5777165_01
Ga68Dotatate PET demonstrating a small focus of intense uptake in the body of the pancreas in keeping with an insulinoma. No other abnormalities were detected elsewhere in the body.
edmcr-2018-170131_g001.jpg
PMC5777165_01_edmcr-2018-170131_g001.jpg
fig1
The patient underwent a 68Ga Dotatate PET that demonstrated a small focus of intense Dotatate uptake in the body of the pancreas in keeping with an insulinoma (Fig. 1).
MRI pancreas T2-weighted image: subtle ill-defined T2 hyperintense lesion (red arrow) approximately 5 mm in diameter approximately 65 mm from the tip of the pancreatic tail. This lesion corresponds with the region of Dotatate uptake in the pancreatic body (Fig. 1).
edmcr-2018-170131_g002.jpg
PMC5777165_01_edmcr-2018-170131_g002.jpg
fig2
T2 hyperintense area of uptake 5 mm in diameter that did not enhance with contrast (Fig. 2).
Endoscopic ultrasound: demonstrating a 6 mm hypoechoic lesion in the mid-body (red arrow) consistent with a small insulinoma, located within 5 mm of the main pancreatic duct (green arrow). No other abnormalities of the pancreas detected.
edmcr-2018-170131_g003.jpg
PMC5777165_01_edmcr-2018-170131_g003.jpg
fig3
To assist with surgical planning, endoscopic ultrasonography (EUS) was performed, which again confirmed a 6 mm hypoechoic lesion in the mid-body of the pancreas consistent with a small insulinoma. The lesion was tattooed with dye injection (Fig. 3).